Skip to main content

Advertisement

SpringerLink
Log in

Should Surgical Resection Be Combined with Imatinib Therapy for Locally Advanced or Metastatic Gastrointestinal Stromal Tumors?

  • Editorial
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Mazur MT, Clark HB. Gastric stromal tumors. Reappraisal of histogenesis. Am J Surg Pathol 1983; 7:507–19

    Article  PubMed  CAS  Google Scholar 

  2. Kindblom LG, Remotti HE, Aldenborg F, Meis-Kindblom JM. Gastrointestinal pacemaker cell tumor (GIPACT): gastrointestinal stromal tumors show phenotypic characteristics of the interstitial cells of Cajal. Am J Pathol 1998; 152:1259–69

    PubMed  CAS  Google Scholar 

  3. Huizinga JD, Thuneberg L, Kluppel M, Malysz J, Mikkelsen HB, Bernstein A. W/kit gene required for interstitial cells of Cajal and for intestinal pacemaker activity. Nature 1995; 373:347–9

    Article  PubMed  CAS  Google Scholar 

  4. Hirota S, Isozaki K, Moriyama Y, et al. Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors. Science 1998; 279:577–80

    Article  PubMed  CAS  Google Scholar 

  5. Corless CL, Fletcher JA, Heinrich MC. Biology of gastrointestinal stromal tumors. J Clin Oncol 2004; 22:3813–25

    Article  PubMed  CAS  Google Scholar 

  6. van der Zwan SM, DeMatteo RP. Gastrointestinal stromal tumor: 5 years later. Cancer 2005; 104:1781–8

    Article  PubMed  CAS  Google Scholar 

  7. Demetri GD, von Mehren M, Blanke CD, et al. Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors. N Engl J Med 2002; 347:472–80

    Article  PubMed  CAS  Google Scholar 

  8. Bonvalot S, Eldweny H, Le Pechoux C, et al. Impact of surgery on advanced gastrointestinal stromal tumors (GIST) in the imatinib era. Ann Surg Oncol 2006; 13:1596–603

    Article  PubMed  CAS  Google Scholar 

  9. Armstrong DK, Bundy B, Wenzel L, et al. Intraperitoneal cisplatin and paclitaxel in ovarian cancer. N Engl J Med 2006; 354:34–43

    Article  PubMed  CAS  Google Scholar 

  10. Stroobants S, Goeminne J, Seegers M, et al. 18FDG-Positron emission tomography for the early prediction of response in advanced soft tissue sarcoma treated with imatinib mesylate (Glivec). Eur J Cancer 2003; 39:2012–20

    Article  PubMed  CAS  Google Scholar 

  11. Scaife CL, Hunt KK, Patel SR, et al. Is there a role for surgery in patients with “unresectable” cKIT+ gastrointestinal stromal tumors treated with imatinib mesylate? Am J Surg 2003; 186:665–9

    Article  PubMed  Google Scholar 

  12. Wu PC, Langerman A, Ryan CW, Hart J, Swiger S, Posner MC. Surgical treatment of gastrointestinal stromal tumors in the imatinib (STI-571) era. Surgery 2003; 134:656–65

    Article  PubMed  Google Scholar 

  13. Rutkowski P, Nowecki Z, Nyckowski P, et al. Surgical treatment of patients with initially inoperable and/or metastatic gastrointestinal stromal tumors (GIST) during therapy with imatinib mesylate. J Surg Oncol 2006; 93:304–11

    Article  PubMed  Google Scholar 

  14. Raut CP, Posner M, Desai J, et al. Surgical management of gastrointestinal stromal tumors after treatment with targeted systemic therapy using kinase inhibitors. J Clin Oncol 2006; 24:2325–31

    Article  PubMed  CAS  Google Scholar 

  15. Demetri G, Van Oosterom AT, Garrett C, et al. Efficacy and safety of sunitinib in patients with advanced gastrointestinal stromal tumour after failure of imatinib: a randomised controlled trial. Lancet 2006; 368:1329–38

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Surgical Oncology, Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts

    Sam S. Yoon MD & Kenneth K. Tanabe MD

Authors
  1. Sam S. Yoon MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kenneth K. Tanabe MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Kenneth K. Tanabe MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Yoon, S.S., Tanabe, K.K. Should Surgical Resection Be Combined with Imatinib Therapy for Locally Advanced or Metastatic Gastrointestinal Stromal Tumors?. Ann Surg Oncol 14, 1784–1786 (2007). https://doi.org/10.1245/s10434-006-9344-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-006-9344-x

Keywords

Search

Navigation